Albothyl

Albothyl

policresulen

Manufacturer:

Takeda

Distributor:

DKSH
Full Prescribing Info
Contents
Policresulen.
Description
1 vaginal suppository contains: Active ingredient: Policresulen 90 mg.
Excipients/Inactive Ingredients: Macrogol 1500 and 4000; water; edetic acid.
Action
Pharmacotherapeutic/indication group/action mechanism: Antiseptic/Gynaecological agent.
Indications/Uses
Local treatment of inflammation or infection and tissue damage of vagina and cervix (e.g. discharge due to bacterial, trichomonal and fungal infections, pressure sores from pessaries), condylomata acuminata, etc.
Protuberance of cervical mucosa (cervical ectopia).
Dosage/Direction for Use
The following information applies unless Albothyl vaginal suppositories have been otherwise prescribed by the doctor.
Please follow these instructions, as otherwise Albothyl vaginal suppositories may not have the desired effect.
Depending on the severity of the condition, one vaginal suppository is administered daily or every other day.
After initial treatment with Albothyl concentrate, 1 Albothyl vaginal suppository is introduced into the vagina every second day in the periods between cauterizations.
Instructions for use/handling: The vaginal suppository should be introduced in the evening.
To facilitate its introduction, the suppository may be moistened with water and then, preferably in the supine position, introduced deep into the vagina.
The additional use of a sanitary towel avoids soiling of clothing and bedding.
The duration of use depends on the nature and severity of the condition and is determined by the doctor
Overdosage
Incidences of overdosage are not known.
If patient forgot an application, do not use twice as many the next time, but continue the treatment at the specified intervals. Inform the doctor accordingly.
If patient should wish to interrupt treatment please notify the doctor.
Contraindications
Albothyl vaginal suppositories must not be administered in cases of hypersensitivity to any of the constituents.
Pregnancy and lactation: Albothyl vaginal suppositories may be used during pregnancy and breastfeeding only where it is strictly indicated, after due consideration of the risks to the mother and child.
There have not been any studies of the risks associated with use during pregnancy in humans, but animal studies have not yielded any evidence of fetal malformation.
It is not known whether the active substance passes into milk.
Special Precautions
Care must be taken not to swallow the suppositories. If Albothyl vaginal suppositories have been swallowed inadvertently, patient should immediately drink plenty of water and consult the doctor.
Albothyl vaginal suppositories cause a sharp stimulation of the healing processes. There is no cause for concern if necrotic tissue from the diseased area is sloughed off even in large amounts.
During the treatment period the use of soaps which cause irritation as well as sexual intercourse must be avoided.
Like all vaginal therapeutics, Albothyl vaginal suppositories should not be used during menstruation.
Albothyl vaginal suppositories is not indicated for use in children and adolescents under 18 years of age or in postmenopausal women, as to date there is no experience in these age groups.
Protect the eyes from Albothyl vaginal suppositories. In case of contact with Albothyl vaginal suppositories, the eyes must be thoroughly rinsed out at once with water; it may be necessary to consult an ophthalmologist.
If textiles or leather come into contact with Albothyl vaginal suppositories, they should be immediately rinsed with water before drying.
Effects on the ability to drive and to use machines: There are no known effects on the ability to drive or to operate machinery.
Use In Pregnancy & Lactation
Pregnancy and lactation: Albothyl vaginal suppositories may be used during pregnancy and breastfeeding only where it is strictly indicated, after due consideration of the risks to the mother and child.
There have not been any studies of the risks associated with use during pregnancy in humans, but animal studies have not yielded any evidence of fetal malformation.
It is not known whether the active substance passes into milk.
Adverse Reactions
Ovulas: Very common: dryness of the vagina.
Common discharge of shreds of mucous membrane.
If severe local irritation occurs Albothyl vaginal suppositories should be discontinued and an alternate antibacterial therapy considered.
The following additional undesirable effects have been reported for use of preparations containing policresulen: urticaria, systemic allergic reactions (e.g. angioedema, generalized urticaria) up to anaphylaxis, vaginal candidiasis, pruritus vulvae, discharge of shreds of mucous membrane, discomfort, dryness of the vagina, sensation of a foreign body being present in the vagina.
If patient experiences any side effects not listed in this monograph, make sure patient informs a doctor or pharmacist.
Drug Interactions
Albothyl vaginal suppositories are intended exclusively for local use. The use of other local drugs on the same area should be avoided during treatment with Albothyl, since interactions cannot be ruled out.
Please note that this information also applies to drugs which patient might have used recently.
Storage
Albothyl vaginal suppositories stored below 25°C remain unchanged for 2 years.
Note: Any spots on the vaginal suppositories are due to the natural appearance of the suppository base and do not affect the applicability, effectiveness and tolerability.
ATC Classification
G01AX03 - policresulen ; Belongs to the class of other antiinfectives and antiseptics. Used in the treatment of gynecological infections.
Presentation/Packing
Vag supp 90 mg x 6's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in